Hello everyone..I am reaching out to all of you because My cousin, Muralimanohar (Mano), was diagnosed with Acute Lymphoblastic Leukemia (ALL) on July 16 2018. He has a very young family with a 2.5 yrs old daughter named Mirra and his wife Vinodhini. He had been feeling anemic for the past week prior to the diagnosis and the news came as a shock to for all of us. Doctors advised that we start Chemotherapy asap so all arrangements were made to start Chemotherapy on July 19 at the  Apollo Cancer Specialty Hospital in Chennai, India . The recommended treatment is 8 cycles of chemotherapy following the Hyper - CVAD regimen. The initial estimate for the cost of the treatment was 21 Lacs INR. So we had made arrangements with our savings and help from our family. However there were some complications during the 2nd and 4th cycle where my cousin contracted some infections and had to be treated with multiple antibiotics and extended stays at the hospital. The cost till today is 20.2 Lacs INR and we still have 4 more cycles to go. In the meantime, he had to resign from his job due to extended absence. We expect the cost for the next 4 treatments to be about the same as the first 4 treatments as doctors have advised the reactions to medicine will be similar and  the cumulative effects of the chemotherapy means that it will take longer for the  bone marrow to recover to produce the blood cells which means possible longer stays at the hospital.  Please find attached the following

1)Medical bill summary till date
2)Discharge summary after 4th cycle with detailed explanation of the condition from time of diagnosis

Therefore, to help with the rest of the costs, I have created this milaap page. If you could support him by making a donation and then sharing it with your network, I would greatly appreciate it. Any amount of donation helps me get closer to my goal. Manohar is a very strong and positive person and has been keeping his chin up in these tough times and I am looking forward to seeing him get back to his normal life asap.